Improved growth of toddlers fed a milk containing synbiotics - PubMed (original) (raw)
Randomized Controlled Trial
Affiliations
- PMID: 21393113
Free article
Randomized Controlled Trial
Improved growth of toddlers fed a milk containing synbiotics
Agus Firmansyah et al. Asia Pac J Clin Nutr. 2011.
Free article
Abstract
Bifidobacterium longum (BL999), Lactobacillus rhamonosus (LPR), prebiotics (inulin and fructo-oligosaccharides), and long-chain polyunsaturated fatty acids (LCPUFA) are believed to have health benefits. In a randomized, double-blind, controlled trial we compared growth and development of toddlers fed milk containing synbiotics (BL999, LPR, and prebiotics) and LCPUFA or a control milk. Three hundred and ninety three healthy, 12 month-old toddlers were fed approximately 400 mL/day for 12 months. Anthropometric measurements were taken at 12, 14, and 16 months. Toddlers' response to measles and hepatitis A vaccine was measured at 16 months, and Bayley scale for motor, cognitive, and behavioral functions made at 24 months. The primary outcome was weight gain between 12 and 16 months. Secondary outcomes were gain in length, head circumference, and body mass index, gastrointestinal tolerance (stool characteristics), stool bacterial counts, safety, anti-vaccine IgG, and neurodevelopment. Weight gain was greater in the synbiotics group (mean±SD, 7.57±4.13 g/day) compared with the control group (6.64±4.08 g/day). The difference of 0.93 g/day (with a 95% confidence interval of 0.12 to 1.75) is significant (p=0.025). The gain in the synbiotics group resulted in a change in z-score weight-for-age closer to WHO Child Growth Standard. There was a significant increase in lactobacilli and enterococci counts between 12 months and 16 months in the synbiotic group. We conclude that in healthy toddlers milk containing synbiotics and LCPUFA provides better growth and promotes favorable gut colonization, as shown by higher Lactobacillus counts.
Similar articles
- Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial.
Chouraqui JP, Grathwohl D, Labaune JM, Hascoet JM, de Montgolfier I, Leclaire M, Giarre M, Steenhout P. Chouraqui JP, et al. Am J Clin Nutr. 2008 May;87(5):1365-73. doi: 10.1093/ajcn/87.5.1365. Am J Clin Nutr. 2008. PMID: 18469260 Clinical Trial. - Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.
Meli F, Puccio G, Cajozzo C, Ricottone GL, Pecquet S, Sprenger N, Steenhout P. Meli F, et al. BMC Pediatr. 2014 Dec 20;14:306. doi: 10.1186/s12887-014-0306-3. BMC Pediatr. 2014. PMID: 25527244 Free PMC article. Clinical Trial. - The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study.
Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kosikowski W, Szczerbiński M, Gantzel J, Cukrowska B. Skrzydło-Radomańska B, et al. Nutrients. 2020 Jul 5;12(7):1999. doi: 10.3390/nu12071999. Nutrients. 2020. PMID: 32635661 Free PMC article. Clinical Trial. - Dietary PUFA for preterm and term infants: review of clinical studies.
Fleith M, Clandinin MT. Fleith M, et al. Crit Rev Food Sci Nutr. 2005;45(3):205-29. doi: 10.1080/10408690590956378. Crit Rev Food Sci Nutr. 2005. PMID: 16048149 Review. - Effects of inulin-type fructans, galacto-oligosaccharides and related synbiotics on inflammatory markers in adult patients with overweight or obesity: A systematic review.
Fernandes R, do Rosario VA, Mocellin MC, Kuntz MGF, Trindade EBSM. Fernandes R, et al. Clin Nutr. 2017 Oct;36(5):1197-1206. doi: 10.1016/j.clnu.2016.10.003. Epub 2016 Oct 8. Clin Nutr. 2017. PMID: 27771020 Review.
Cited by
- The effects of prebiotic, probiotic or synbiotic supplementation on overweight/obesity indicators: an umbrella review of the trials' meta-analyses.
Rasaei N, Heidari M, Esmaeili F, Khosravi S, Baeeri M, Tabatabaei-Malazy O, Emamgholipour S. Rasaei N, et al. Front Endocrinol (Lausanne). 2024 Mar 20;15:1277921. doi: 10.3389/fendo.2024.1277921. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38572479 Free PMC article. - Gut Microbiome-Targeted Nutrition Interventions and Growth among Children in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.
Addae HY, Apprey C, Kwarteng A. Addae HY, et al. Curr Dev Nutr. 2024 Feb 14;8(3):102085. doi: 10.1016/j.cdnut.2024.102085. eCollection 2024 Mar. Curr Dev Nutr. 2024. PMID: 38455707 Free PMC article. - Long-chain polyunsaturated fatty acids influence colorectal cancer progression via the interactions between the intestinal microflora and the macrophages.
Peng D, Wang Y, Yao Y, Yang Z, Wu S, Zeng K, Hu X, Zhao Y. Peng D, et al. Mol Cell Biochem. 2024 Nov;479(11):2895-2906. doi: 10.1007/s11010-023-04904-y. Epub 2024 Jan 13. Mol Cell Biochem. 2024. PMID: 38217838 Review. - Efficacy and Safety of Bifidobacterium longum Supplementation in Infants: A Meta-Analysis of Randomized Controlled Trials.
Guo H, Fan M, Hou T, Li Y, Wang S, Wang X, Peng H, Wang M, Wu T, Zhang Y. Guo H, et al. Foods. 2023 Dec 12;12(24):4451. doi: 10.3390/foods12244451. Foods. 2023. PMID: 38137255 Free PMC article. Review. - Effects of probiotics on neurocognitive outcomes in infants and young children: a meta-analysis.
Lin FL, Chen CM, Sun CK, Cheng YS, Tzang RF, Chiu HJ, Wang MY, Cheng YC, Hung KC. Lin FL, et al. Front Public Health. 2023 Dec 5;11:1323511. doi: 10.3389/fpubh.2023.1323511. eCollection 2023. Front Public Health. 2023. PMID: 38115853 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical